Improving Quality Care Through the Lung Ambition Alliance

ILC2: Initiatives in Lung Cancer Care, Grant Applications Now Open for Projects to Transform Patient Care and Improve the Patient Experience

The ILC2 program is inviting patient and caregiver organizations registered as non-profit in their country to submit proposals for projects that can potentially transform patient care in countries around the world.

The program has been created in recognition of the high variation in lung cancer management around the world, and the very specific local barriers to quality care that must be considered when developing patient centric solutions to address them.

Please review the summary guidance below before starting your application. Applications require the completion of an online form, which must be submitted by 31 January 2020 on the separate application portal.

ILC2 grant applications will be reviewed and selected by the four founding partners of the Lung Ambition Alliance; the Global Lung Cancer Coalition, Guardant Health, the International Association for the Study of Lung Cancer and AstraZeneca. Funding for the ILC2 grant is provided by AstraZeneca.

More information: https://www.lungambitionalliance.com/....